Related Experiment Video
Updated: Jul 17, 2026
09:40
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Aurora B expression correlates with aggressive behaviour in glioblastoma multiforme.
Weifen F Zeng1, Kapila Navaratne, Richard A Prayson
1The Brain Tumor Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Journal of Clinical Pathology
|February 1, 2007
Summary
Overexpression of Aurora B, a mitotic protein, is linked to shorter survival in glioblastoma (GBM) patients. This finding suggests Aurora B as a potential prognostic marker and therapeutic target for GBM.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Genomic instability and chromosomal abnormalities are hallmarks of cancer.
- Mitotic proteins, including the Aurora kinase family, play crucial roles in chromosome segregation during cell division.
- Aneuploidy, a common feature in malignant gliomas like glioblastomas (GBMs), suggests potential involvement of mitotic regulators.
Purpose of the Study:
- To investigate the role of Aurora B overexpression in the clinical behavior of glioblastomas.
- To assess if Aurora B expression levels correlate with patient survival in GBM.
Main Methods:
- Analysis of Aurora B expression levels in 25 prospectively collected GBM samples.
- Correlation of Aurora B expression with clinical data, including patient survival.
- Assessment of relationships between Aurora B expression and tumor proliferation status, age, and common molecular alterations in GBM.
Main Results:
- Aurora B expression levels were significantly correlated with shortened patient survival in GBM.
- Aurora B overexpression was not directly associated with patient age, tumor proliferation rates, or common molecular changes in GBM.
- Elevated Aurora B levels indicate a potential prognostic factor for GBM patient outcomes.
Conclusions:
- Aurora B overexpression may serve as a prognostic indicator of impaired survival in glioblastoma patients.
- Aurora B represents a potential novel therapeutic target for managing glioblastoma.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...